TCM
PFE icon

Triumph Capital Management’s Pfizer PFE Stock Holding History

Triumph Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
60,207
+3,798
+7% +$99.3K 0.26% 89
2026
Q1 		$1.58M Buy
56,409
+38,022
+207% +$1.01M 0.32% 68
2025
Q4 		$458K Buy
18,387
+9,411
+105% +$237K 0.1% 185
2025
Q3 		$229K Sell
8,976
-9,126
-50% -$225K 0.06% 285
2025
Q2 		$439K Buy
18,102
+9,466
+110% +$221K 0.13% 179
2025
Q1 		$219K Sell
8,636
-1,647
-16% -$43.1K 0.07% 254
2024
Q4 		$273K Buy
10,283
+1,717
+20% +$46.6K 0.09% 227
2024
Q3 		$248K Sell
8,566
-37,402
-81% -$1.09M 0.09% 234
2024
Q2 		$1.29M Buy
45,968
+18,161
+65% +$500K 0.5% 44
2024
Q1 		$771K Buy
27,807
+2,987
+12% +$82.9K 0.31% 79
2023
Q4 		$715K Buy
24,820
+9,744
+65% +$295K 0.3% 74
2023
Q3 		$500K Buy
15,076
+946
+7% +$33.5K 0.23% 101
2023
Q2 		$518K Buy
14,130
+2,572
+22% +$100K 0.23% 93
2023
Q1 		$472K Sell
11,558
-9,450
-45% -$408K 0.24% 80
2022
Q4 		$1.08M Buy
21,008
+8,438
+67% +$405K 0.58% 36
2022
Q3 		$550K Buy
12,570
+7,226
+135% +$351K 0.3% 79
2022
Q2 		$280K Sell
5,344
-1,497
-22% -$76.3K 0.15% 150
2022
Q1 		$354K Buy
+6,841
New +$355K 0.15% 136

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Triumph Capital Management's PFE Position: Q2 2026 in Review

Triumph Capital Management increased its Pfizer (PFE) stake by 6.7% in Q2 2026, buying an estimated $99.3K and bringing the position to 60,207 shares worth $1.45M. The position accounts for 0.26% of the portfolio, ranked #89.

Triumph Capital Management first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.58M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Triumph Capital Management held 60,207 shares of Pfizer worth $1.45M as of Q2 2026.
  • Triumph Capital Management bought 3,798 Pfizer shares in Q2 2026, an estimated $99.3K.
  • Pfizer made up 0.26% of Triumph Capital Management's portfolio in Q2 2026, its #89 holding.
  • Triumph Capital Management first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
  • Triumph Capital Management's Pfizer position peaked at $1.58M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.